Physiomics — Corporate Update (January 2024)

7 slides from Physiomics's corporate update, Jan 29, 2024

Slide 2: Disclaimer
Disclaimer The information contained in this presentation ("Presentation") has been prepared by Physiomics Plc (the "Company"). This Presentation has not been approved by an authorised person in accordance with Section 21 of the Financial Services and Markets Act 2000 (" FSMA"). This Presentation sh
Slide 3: Agenda
Agenda 1. Introducing the new CEO and the transition 2. Immediate Areas of Focus Dr Peter Sargent Dr Jim Millen 3. Q&A CEO NED Chairman Slide 3 Copyright © Physiomics Plc 2024 - www.physiomics.co.uk
Slide 4: New CEO: Introducing Dr Peter Sargent
New CEO: Introducing Dr Peter Sargent Head of Business Innovation Scout, Development for British Biocell National Institute for PhD (MRC International Health Research Industrial Search and Evaluation Worked with UK Physiomics Collaborative) role developing Government around Biochemistry and partners
Slide 5: Immediate Areas of Focus: Growth and Profit
Immediate Areas of Focus Growth and Profit 1. ü Driving the pipeline 2. ü Accelerate service roll- 3. ü Retain focus on Innovate ü Increasing conversion out funding trial ü Diversifying client base ü Offer development ü Refresh plans ü Broaden our offer ü Capability build (de novo ü Build on existin